Association for Accessible Medicines
FDANonrulemakingFDA-2013-D-1543

Nonproprietary Naming of Biological Products

RIN
Last modified
May 28, 2019
Comment window
closed 2639d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between May 9, 2019 and May 9, 2019. 58 other organizations filed here. The comment window closed 2639d ago.

What Association for Accessible Medicines filed (1)

May 9, 2019· Comment from Association for Accessible Medicines ("AAM")· FDA-2013-D-1543-0248

Comments of the Association for Accessible Medicines and the Biosimilars Council on behalf of our member companies regarding Docket No. FDA-2013-D-1543: Nonproprietary Naming of Biological Products: Update; Draft Guidance for Industry; Availability. The Association for Accessible Medicines (AAM), and its Biosimilars Council (Council) (collectively referred to in these comments as AAM), submit these comments to FDAs updated guidance on Nonproprietary Naming of Biological Products. Please find full comment letter enclosed.

Abstract

No abstract recorded.

View on regulations.gov →